DrugAug 2, 2017
SCA Pharmaceuticals BUPIVacaine HCl 0.2% IN 0.9% Sodium Chloride 250 mL Bag Preservative recall — FDA D-1007-2017
Lack of Assurance of Sterility; product has the potential to leak.
Class IIFDA: TerminatedSCA Pharmaceuticals
Recall history in this database
Classification mix: Class II: 59, Class I: 11, Class III: 1.
DrugAug 2, 2017
SCA Pharmaceuticals BUPIVacaine HCl 0.1% PF (From 0.75%) in 0.9% Sodium Chloride, 250 mL recall — FDA D-1005-2017
Lack of Assurance of Sterility; product has the potential to leak.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugAug 2, 2017
SCA Pharmaceuticals PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride recall — FDA D-1004-2017
Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 2g recall — FDA D-0876-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals HYDROmorphone HCL in 0.9% Sodium Chloride injectable, 0.2 mg per ml recall — FDA D-0875-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total recall — FDA D-0871-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL recall — FDA D-0873-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals MAGNESIUM Sulfate added to 100 mL 0.9% Sodium Chloride injectable, 4g recall — FDA D-0878-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL recall — FDA D-0872-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total recall — FDA D-0870-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 3g recall — FDA D-0877-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals PHENYLephrine HCL in 0.9% Sodium Chloride injectable, 10 mg recall — FDA D-0879-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJun 7, 2017
SCA Pharmaceuticals fentaNYL (as citrate) in 100mL 0.9% Sodium Chloride injectable,20 mcg recall — FDA D-0874-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugApr 12, 2017
SCA Pharmaceuticals Vancomycin HCl 750 mg added to 250 mL 0.9% Sodium Chloride For IV Use recall — FDA D-0644-2017
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Class IFDA: TerminatedSCA Pharmaceuticals
DrugApr 12, 2017
SCA Pharmaceuticals Vancomycin HCl 1.25 g added to 0.9% Sodium Chloride 250 mL Bag For IV recall — FDA D-0641-2017
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Class IFDA: TerminatedSCA Pharmaceuticals
DrugApr 12, 2017
SCA Pharmaceuticals Vancomycin HCl 1.5 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use recall — FDA D-0642-2017
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Class IFDA: TerminatedSCA Pharmaceuticals
DrugApr 12, 2017
SCA Pharmaceuticals Vancomycin HCl 750 mg added to 5% Dextrose 250 mL For IV Use Only recall — FDA D-0645-2017
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Class IFDA: TerminatedSCA Pharmaceuticals
DrugApr 12, 2017
SCA Pharmaceuticals Vancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use recall — FDA D-0640-2017
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Class IFDA: TerminatedSCA Pharmaceuticals
DrugApr 12, 2017
SCA Pharmaceuticals Vancomycin HCl 1.5 gram added to 5% Dextrose 500 mL Total Approximate recall — FDA D-0643-2017
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Class IFDA: TerminatedSCA Pharmaceuticals
DrugApr 12, 2017
SCA Pharmaceuticals Vancomycin HCl 1.25 g added to 5% Dextrose 250 mL Bag For IV Use Only recall — FDA D-0639-2017
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Class IFDA: TerminatedSCA Pharmaceuticals
DrugJun 17, 2015
SCA Pharmaceuticals PHENYLephrine HCl 50 mg in 0.9% Sodium Chloride 250 mL bag recall — FDA D-1133-2015
Labeling: Label Mix-Up: Product is incorrectly labeled as phenylephrine 50 mg in 0.9% sodium chloride rather than phenylephrine 50 mg in 5% dextrose.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugApr 29, 2015
SCA Pharmaceuticals Droperidol injection, 2.5 mg/mL, 5 mg Total Dose, 2 mL Fill Volume per recall — FDA D-0965-2015
Presence of particulate.
Class IIFDA: TerminatedSCA Pharmaceuticals
DrugJan 21, 2015
SCA Pharmaceuticals Glycopyrrolate injection, 0.2 mg per mL (1 mg/5 mL), 5 mL Fill in 10 mL recall — FDA D-0339-2015
Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" and "3" making the actual "Use By 3/2015" date appear to read "Use By8/2015".
Class IIFDA: TerminatedSCA Pharmaceuticals
Understanding this recall history
This page summarizes recall records in which the official source identifies SCA Pharmaceuticals as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.